Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children.
about
Medical therapies for parenteral nutrition-associated cholestasis in term and preterm infantsAlterations in parenteral nutrition management for the treatment of parenteral nutrition-associated cholestasis in term and preterm infantsControversies in the Mechanism of Total Parenteral Nutrition Induced PathologyFish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver diseaseFish Oil Lipid Emulsion-Associated Sea-Blue Histiocyte Syndrome in a Pediatric Patient.Pediatric parenteral nutrition: putting the microscope on macronutrients and micronutrients.Innovative parenteral and enteral nutrition therapy for intestinal failure.The use of Omegaven in treating parenteral nutrition-associated liver disease.Parenteral nutrition-associated liver complications in children.Prevention of parenteral nutrition-associated liver disease in children.Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oilNatural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation.The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice.Effects of parenteral soybean oil lipid emulsion on the long-chain polyunsaturated fatty acid profile in very-low-birth-weight infantsIntravenous lipids for preterm infants: a review.Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease.Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm PigsLow-Dose Intravenous Soybean Oil Emulsion for Prevention of Cholestasis in Preterm Neonates.Effect of a fish oil-containing beverage on changes in plasma lipid fatty acids in patients with malabsorptionParenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.Current issues in the management of intestinal failure.Risk factors for parenteral nutrition–associated liver disease following surgical therapy for necrotizing enterocolitis: A Glaser Pediatric Research Network Study [corrected].Low-Dose Parenteral Soybean Oil for the Prevention of Parenteral Nutrition-Associated Liver Disease in Neonates With Gastrointestinal Disorders.Parenteral nutrition-associated liver disease in adult and pediatric patients.The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD).Short-term intravenous fish oil and pediatric intestinal failure associated liver disease: 3-year follow-up on liver function and nutrition.Effects of protein/nonprotein caloric intake on parenteral nutrition associated cholestasis in premature infants weighing 600-1000 grams.Variability of resting energy expenditure in infants and young children with intestinal failure-associated liver diseaseThe effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants.Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.Use of Fish Oil-Based Lipid Emulsions in Infants With Intestinal Failure-Associated Liver Disease: A Case Series.New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs.Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.New advances in the management of children with intestinal failure.Omega-3 long chain polyunsaturated Fatty acids for treatment of parenteral nutrition-associated liver disease: a review of the literatureProvision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates.Review and clinical update on parenteral nutrition-associated liver disease.Lipid emulsions in parenteral nutrition: current applications and future developments.Risks and benefits of prophylactic cyclic parenteral nutrition in surgical neonates.
P2860
Q24240289-5DC2A25B-8E03-48CF-8A38-0B71EF579E31Q24240633-83C77D1D-A70F-48C9-9AB8-45A00467CB9BQ26865276-E5A7B579-5270-4583-9A93-A9208F7CDBB3Q28085111-361761B0-BC0C-4791-8D19-04AB7F68F26AQ33424368-FCD165FA-AC60-418F-B2F8-633C96AC1DA9Q33482757-F3D07B60-4C34-4C5E-BD70-1F2342FB5176Q33641177-8287A7E4-DA8A-43E8-A1FB-76B867DFEA72Q34174212-6E8AE469-D535-4B03-8532-EEBAF348EC1FQ34523863-371931AB-A8CD-43D2-97D4-C5EDA749C1EFQ34572743-98168F5D-8DC7-4C61-8226-C86D6D21562CQ34624462-B6F1720C-381C-4304-92E0-7F7DF8276136Q34769049-736AF872-F2AF-40DE-A3AA-0B11AD667153Q34778491-4EDD349B-7E32-4930-8B26-AF457D5E1450Q35069816-0A86F3EF-0941-48AB-B9A9-8F4B030A9512Q35076642-527C7ADF-723D-4AF4-BC08-EC436B5DB4AAQ35679248-AD2F044C-3A96-4F73-BFF8-272B9655FBD3Q35858834-DEF1ED3F-05DE-420C-909A-9219DFCC3710Q35956445-72070574-C771-4F5D-9F9C-46D769F6C6F5Q35972540-80D23EDD-9541-421E-AD32-776D1FFD04CEQ36004900-F5BCA898-8373-404A-B87B-19F1B01D9404Q36121045-DE049E87-C9F5-490B-B9A4-6424A237F847Q36239681-A125A939-0522-482D-AFE3-88BEE897CA65Q36328532-907C388D-B331-4CB1-A3E8-902F5DC803B6Q36506091-9B1D4190-FBB7-4C2F-9FF1-8A188669B783Q36538113-AA2907E4-4498-4B4E-AD21-7A901E64959DQ36557747-522D75F5-0A6F-4B09-8FB4-9CC628B7D489Q36975595-22612987-B724-4228-A3C6-AEBE7A168E3FQ37260804-6A41969E-E124-4396-90DC-07381D8571BDQ37274324-1300189C-B290-4357-A8B0-E737CCE4FF44Q37296480-3D82EAE0-74BC-46E7-8FA3-79F425129408Q37538088-33FFEDA6-A3D8-46C4-819B-89D8D5141260Q37576936-BE24E073-DA3C-469E-A7A8-860F5EA401C0Q37603224-8A167C24-6B15-421C-BE04-2D9DFB60945EQ37736147-F6DEA78E-3D20-48E0-AF2B-B32EB31E4E93Q37970665-186F1729-A456-4ECB-A825-56961F74C46BQ38000190-D5F0E984-83FC-45D5-959B-44D8C9A5A153Q38024333-76FF024E-855E-4713-A5D4-2389FB784103Q38054057-5F2F636C-4ADC-4776-85A5-703EC597CAE9Q38126971-7BEF5B9B-949B-4E19-B0F6-45AAF9784EE1Q38150924-4BC16E0B-7EA3-4C57-988D-D73DA8188F18
P2860
Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Role of lipid emulsions in cho ...... enteral nutrition in children.
@ast
Role of lipid emulsions in cho ...... enteral nutrition in children.
@en
Role of lipid emulsions in cho ...... enteral nutrition in children.
@nl
type
label
Role of lipid emulsions in cho ...... enteral nutrition in children.
@ast
Role of lipid emulsions in cho ...... enteral nutrition in children.
@en
Role of lipid emulsions in cho ...... enteral nutrition in children.
@nl
prefLabel
Role of lipid emulsions in cho ...... enteral nutrition in children.
@ast
Role of lipid emulsions in cho ...... enteral nutrition in children.
@en
Role of lipid emulsions in cho ...... enteral nutrition in children.
@nl
P2093
P2860
P1476
Role of lipid emulsions in cho ...... enteral nutrition in children.
@en
P2093
A Jobert-Giraud
F Lacaille
J C Fournet
P2860
P304
P356
10.1177/0148607100024006345
P577
2000-11-01T00:00:00Z